Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin + R-CHOP in Untreated Aggressive DLBCL
NCT02531308Phase 2Terminated
- Sponsor
- Rush University Medical Center
- Start
- Jul 2015
- Primary completion
- Jul 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of metformin in diffuse large B-cell lymphoma (DLBCL), sponsored by Rush University Medical Center. Started Jul 2015; status: terminated.
02
Drugs
metformin
03
Conditions
diffuse large B-cell lymphoma (DLBCL)
Beyond the preview
Go deeper on NCT02531308.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02531308.